Key result
Prkar1a inactivation in both stromal and Sertoli cells induced large-cell calcifying Sertoli cell tumors through aberrant WNT4 signaling.
Why the study?
Large-cell calcifying Sertoli cell tumors are frequent in male Carney complex patients, but their pathogenesis and origin remain elusive.
Prkar1a inactivation in both stromal and Sertoli cells is required for LCCSCT development in Carney complex, driven by PKA-induced paracrine circuits and aberrant WNT4 signaling.
Should not alter Carney complex management; leaves open stromal-Sertoli PKA-WNT4 circuits as therapeutic targets.
Large-cell calcifying Sertoli cell tumors (LCCSCTs) are among the most frequent lesions occurring in male Carney complex (CNC) patients. Although they constitute a key diagnostic criterion for this rare multiple neoplasia syndrome resulting from inactivating mutations of the tumor suppressor PRKAR1A, leading to unrepressed PKA activity, LCCSCT pathogenesis and origin remain elusive. Mouse models targeting Prkar1a inactivation in all somatic populations or separately in each cell type were generated to decipher the molecular and paracrine networks involved in the induction of CNC testis lesions. We demonstrate that the Prkar1a mutation was required in both stromal and Sertoli cells for the occurrence of LCCSCTs. Integrative analyses comparing transcriptomic, immunohistological data and phenotype of mutant mouse combinations led to the understanding of human LCCSCT pathogenesis and demonstrated PKA-induced paracrine molecular circuits in which the aberrant WNT4 signal production is a limiting step in shaping intratubular lesions and tumor expansion both in a mouse model and in human CNC testes.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied Carney complex (CNC) associated Large-cell calcifying Sertoli cell tumors (LCCSCTs). Prkar1a inactivation vs. Wild-type mice was evaluated on Tumor formation and molecular pathway alterations. Prkar1a inactivation in both stromal and Sertoli cells induced large-cell calcifying Sertoli cell tumors through aberrant WNT4 signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: